Latest stories on PPCB
Propanc Biopharma to commence first-in-human study of PRP in February
The Fly56 · neutralproduct/pr
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
Business Insider63 · neutralproduct/pr
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
GlobeNewswire67 · bullishproduct/pr
Propanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition
InvestorsHub73 · bullishproduct/pr
Why Is Penny Stock Propanc Biopharma (PPCB) Up 245% Today?
TipRanks58 · neutralgeneral
Propanc Biopharma announces new preclinical data for PRP in PDAC
The Fly59 · neutralproduct/pr
Propanc Biopharma starts finalization of clinical trial protocol for PRP study
The Fly56 · neutralproduct/pr
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
Business Insider73 · bullishproduct/pr
Propanc highlights PRP as potential therapy against RAS-driven cancers
The Fly63 · neutralproduct/pr
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
Business Insider63 · neutralproduct/pr
Propanc reports new preclinical data for PRP in pancreatic ductal adenocarcinoma
The Fly59 · neutralproduct/pr
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
Business Insider71 · bullishgeneral
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
StockTitan63 · neutralproduct/pr
Propanc Biopharma, Inc. (PPCB) files 8-K
SEC 8-K50 · neutralgeneral
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
Business Insider56 · neutralgeneral
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd | PPCB Stock News
StockTitan63 · neutralproduct/pr
Propanc Biopharma Launches $5 Million Share Repurchase, Signaling Confidence in Growth Path
MarketChameleon71 · bullishgeneral
Propanc Biopharma launches $5M share repurchase program
Seeking Alpha71 · bullishgeneral
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program | PPCB Stock News
StockTitan71 · bullishgeneral
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study | PPCB Stock News
StockTitan63 · neutralproduct/pr
PPCB Stock Surges Over 200% Just Days After Implementing Reverse Share Split – What’s Driving Today’s Smashing Rally?
Stocktwits News73 · bullishgeneral
PPCB Authorizes $5 Million Share Repurchase, Highlighting Confidence Amid Advancing Cancer Treatment Pipeline
MarketChameleon71 · bullishgeneral